
TENAYA THERAPEUTICS INC
TNYA · NASDAQ
Updated at 2026-11-16 21:26:12
- Today's High
- $0.35
- Today’s Low
- $0.33
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.35
- Previous Close
- $0.34
- Volume
- 1.3M
- Market Cap
- $79.59M
- P/E Ratio
- --
- EPS
- $-0.48
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 171 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, UNITED STATES, 94080
- Country
- US
- Listing Date
- 2021-07-30
- Fiscal Year End
- December
- Shares Outstanding
- 227.93M
- CIK
- 0001858848
- Website
- www.tenayatherapeutics.com
Tenaya Therapeutics Inc. is a pioneering clinical-stage biotechnology firm that is revolutionizing the treatment of heart disease through its proprietary engineered heart cell platform. The company boasts a promising pipeline of innovative gene therapies and regenerative treatments designed to meet substantial unmet needs in cardiovascular medicine, positioning itself for significant growth within the biopharmaceutical landscape. Tenaya's commitment to scientific integrity, coupled with its focus on enhancing patient outcomes, presents a compelling investment opportunity for institutional investors seeking exposure to advancements in cardiac care and the expanding cardiovascular therapy market.
Financial Metrics
Revenue
2026-09-30
$1.69M
2026-06-30
$1.11M
2026-03-31
$225K
2025-12-31
$0
Operating Expenses
2026-09-30
$21.26M
2026-06-30
$45.19M
2026-03-31
$18.52M
2025-12-31
$24.72M
Net Income
2026-09-30
-$18.93M
2026-06-30
-$43.39M
2026-03-31
-$19.27M
2025-12-31
-$20.17M
Net Profit Margin
2026-09-30
-1.11K%
2026-06-30
-3.9K%
2026-03-31
-8.56K%
2025-12-31
--
Earnings Per Share
2026-09-30
$-0.08
2026-06-30
$-0.09
2026-03-31
$-0.09
2025-12-31
$-0.12
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-09-30
-$18.42M
2026-06-30
-$41.69M
2026-03-31
-$17.5M
2025-12-31
-$18.34M
Effective Tax Rate
2026-09-30
--
2026-06-30
--
2026-03-31
--
2025-12-31
--
| Item | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | $1.69M | $1.11M | $225K | $0 |
| Operating Expenses | $21.26M | $45.19M | $18.52M | $24.72M |
| Net Income | -$18.93M | -$43.39M | -$19.27M | -$20.17M |
| Net Profit Margin | -1.11K% | -3.9K% | -8.56K% | -- |
| Earnings Per Share | $-0.08 | $-0.09 | $-0.09 | $-0.12 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$18.42M | -$41.69M | -$17.5M | -$18.34M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.